Change in odor identification impairment is associated with improvement with cholinesterase inhibitor treatment in mild cognitive impairment

Manuscript Number: 

17-0497R1

Author(s): 
Howard Andrews, Karen Bell, Richard E. Chunga, Adam Ciarleglio, D. P. Devanand, Edward D. Huey, Cody Lentz, Gregory H. Pelton, Peter Schofield, Jennifer M. Scodes, Yaakov Stern

Disclosures

Howard Andrews

  • Nothing to Disclose

Karen Bell

  • Equity:
    Baxter: stock

Richard E. Chunga

  • Nothing to Disclose

Adam Ciarleglio

  • Nothing to Disclose

D. P. Devanand

  • Consulting Fees:
    Astellas: Scientific Advisory Board Axovant: Educational Advisory Board Eisai: Data Safety Monitoring Board Genentech: Scientific Advisory Board
    Grants
    • Agency: 
      Avanir
      Dates: 
      1/1/16-12/31/18

Edward D. Huey

  • Nothing to Disclose

Cody Lentz

  • Nothing to Disclose

Gregory H. Pelton

  • Nothing to Disclose

Peter Schofield

  • Nothing to Disclose

Jennifer M. Scodes

  • Nothing to Disclose

Yaakov Stern

  • Consulting Fees:
    Lilly USA, LLC / Consultant / I receive fees at an hourly rate for my services; Takeda Global Research & Development Center, Inc. /I receive fees at an hourly rate for my services; Axovant Sciences, Inc / I receive fees at an hourly rate for my services.